Filing Flows › Insulet (PODD) › Net income
Insulet (PODD) net income by quarter
Insulet's net income was $141M in Q3 2026 (third quarter 2026), +49% from Q2 2026. Over the last 7 quarters it ranged from $22.5M (Q2 2025) to $141M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $141M | +49% | +61% |
| Q2 2026 | $95.0M | +4% | +322% |
| Q1 2026 | $91.1M | -10% | +157% |
| Q4 2025 | $102M | +16% | — |
| Q3 2025 | $87.6M | +289% | — |
| Q2 2025 | $22.5M | -36% | — |
| Q1 2025 | $35.4M | — | — |
Q3 2026 at a glance
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insulet's net income?
Insulet's net income was $141M in Q3 2026 (third quarter 2026), +49% from Q2 2026.
How has Insulet's net income changed?
Over the last 7 quarters it ranged from $22.5M (Q2 2025) to $141M (Q3 2026).